Mental Health and Kidneys: The Interplay Between Cognitive Decline, Depression, and Kidney Dysfunction in Hospitalized Older Adults
- PMID: 40565866
- PMCID: PMC12194674
- DOI: 10.3390/jcm14124120
Mental Health and Kidneys: The Interplay Between Cognitive Decline, Depression, and Kidney Dysfunction in Hospitalized Older Adults
Abstract
Background: As societies rapidly age, the prevalence of mental health disorders and chronic kidney disease (CKD) is simultaneously rising, and data on the link between these conditions remain inconclusive. This study aimed to investigate the associations among cognitive impairment, depression, and kidney involvement in elderly patients. Methods: A cross-sectional analysis was conducted among hospitalized patients aged ≥65 years. Standardized tools such as the geriatric depression scale (GDS) and Montreal Cognitive Assessment (MoCA) were used to assess depression and cognitive impairment, and kidney function was evaluated using eGFR and albuminuria. Bivariate and multivariate logistic regressions were performed to identify associations. Results: The study population consisted of 719 participants with a median age of 80 years. Kidney and mental health issues were highly prevalent: CKD was identified in 59.4%, cognitive impairment in 74%, and depression in 61.9% of patients. Patients with CKD were older and exhibited lower MoCA scores (p = 0.001), higher GDS scores (p = 0.007), reduced albumin (p < 0.001), lower hemoglobin levels (p < 0.001), and elevated C-reactive protein (p < 0.001). Increased albuminuria was associated with poorer cognition (p < 0.001) but showed no correlation with GDS scores. Additionally, worse cognitive scores (p = 0.001) and increased depression symptoms (p < 0.001) were correlated with declining estimated glomerular filtration rate (eGFR). Conclusions: Cognitive impairment and depressive symptoms are highly prevalent among elderly hospitalized patients. Cognitive decline correlates with increased albuminuria and reduced eGFR, while depression worsens with declining kidney function. These findings highlight the complex interplay between renal health and neuropsychiatric conditions in aging populations.
Keywords: albuminuria; chronic kidney disease; cognitive impairment; depression; older population.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
The effect of vitamin B6 on cognition.Cochrane Database Syst Rev. 2003;(4):CD004393. doi: 10.1002/14651858.CD004393. Cochrane Database Syst Rev. 2003. PMID: 14584010
-
Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD015196. doi: 10.1002/14651858.CD015196.pub2. Cochrane Database Syst Rev. 2022. PMID: 35994403 Free PMC article.
-
Assessing Renal Function in Chronic Kidney Disease: A Comparative Evaluation of Glomerular Filtration Rate Prediction Equations in the North-Central Region of Nigeria.Cureus. 2025 May 21;17(5):e84577. doi: 10.7759/cureus.84577. eCollection 2025 May. Cureus. 2025. PMID: 40546627 Free PMC article.
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2023 Jul 19;7:CD007751. doi: 10.1002/14651858.CD007751.pub3. PMID: 21975774 Updated.
References
-
- Harrison T.G., Tam-Tham H., Hemmelgarn B.R., Elliott M., James M.T., Ronksley P.E., Jun M. Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis. Can. J. Cardiol. 2019;35:77–91. doi: 10.1016/j.cjca.2018.10.014. - DOI - PubMed
-
- Kurella Tamura M., Gaussoin S.A., Pajewski N.M., Chelune G.J., Freedman B.I., Gure T.R., Haley W.E., Killeen A.A., Oparil S., Rapp S.R., et al. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial. J. Am. Soc. Nephrol. 2020;31:2122–2132. doi: 10.1681/ASN.2020010038. - DOI - PMC - PubMed
-
- Pépin M., Ferreira A.C., Arici M., Bachman M., Barbieri M., Bumblyte I.A., Carriazo S., Delgado P., Garneata L., Giannakou K., et al. Cognitive disorders in patients with chronic kidney disease: Specificities of clinical assessment. Nephrol. Dial. Transpl. 2021;37:ii23–ii32. doi: 10.1093/ndt/gfab262. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous